| case report | Q2782326 |
| scholarly article | Q13442814 |
| P2093 | author name string | Yasuhiro Ito | |
| Gordana Pupic | |||
| Marko Buta | |||
| Radan Dzodic | |||
| Zorka Milovanovic | |||
| Jasna Bankovic | |||
| Nikola Tanic | |||
| Zorica Milosevic | |||
| Dragana Lavrnic | |||
| Vedrana Milinkovic | |||
| Tijana Stankovic | |||
| Sonja Stojkovic | |||
| P2860 | cites work | Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer | Q30318256 |
| RET proto-oncogene in the development of human cancer | Q33718087 | ||
| Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. | Q36064845 | ||
| Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer | Q36081611 | ||
| Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells. | Q36677712 | ||
| Why is PTEN an important tumor suppressor? | Q36986667 | ||
| Genetic basis for p53 overexpression in human breast cancer | Q37528810 | ||
| Multiple primary malignancies including colon, stomach, lung, breast, and liver cancer: a case report and literature review | Q37688323 | ||
| Quadruple malignancy in a single patient: a case report and comprehensive review of literature | Q37771807 | ||
| Differential oncogenic potential of activated RAS isoforms in melanocytes | Q40171561 | ||
| Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis | Q40539659 | ||
| The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts | Q41205734 | ||
| Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation | Q41578148 | ||
| Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers | Q41691073 | ||
| The Ras radiation resistance pathway. | Q43612306 | ||
| The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study | Q44679625 | ||
| Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients | Q46116622 | ||
| Loss of heterozygosity for 10q22-10qter in malignant melanoma progression | Q46160835 | ||
| Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients | Q46710025 | ||
| Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer | Q46892013 | ||
| Sentinel lymph node biopsy may be used to support the decision to perform modified radical neck dissection in differentiated thyroid carcinoma. | Q50479592 | ||
| Concurrent alteration of p16 and PTEN tumor suppressor genes could be considered as potential molecular marker for specific subgroups of NSCLC patients. | Q54623612 | ||
| Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas | Q57591220 | ||
| RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma | Q71331640 | ||
| Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas | Q71744061 | ||
| Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma | Q72234184 | ||
| Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer | Q72992810 | ||
| Absence of H- and K-ras oncogene mutations in sporadic medullary thyroid carcinoma | Q73684859 | ||
| Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma | Q73803410 | ||
| Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus | Q74274255 | ||
| The risk of cancer from azathioprine as a treatment for multiple sclerosis | Q75352273 | ||
| Malignancies after renal transplantation during 33 years at a single center | Q80044617 | ||
| P433 | issue | 4 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 1826-1833 | |
| P577 | publication date | 2014-03-15 | |
| P1433 | published in | International Journal of Clinical and Experimental Pathology | Q6051341 |
| P1476 | title | Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy | |
| P478 | volume | 7 |
Search more.